In The News
Former SU2C cancer patient, Emily Whitehead, 12 years old and five years cancer-free, speaks up about her role as face of cancer immunotherapy.
Melissa Skala, PhD, a 2016 recipient of an SU2C Innovative Research Grant, says the IRG program, with its quick turnaround and emphasis on results, is “the way science should be.”
Actress Sonequa Martin-Green Joins SU2C In PSA Encouraging Clinical Trial Participation
Stand Up To Cancer Awards $11M Convergence Research Program Using AI to Investigate Immunotherapies
Tamara Wallace Norman describes her journey with breast cancer as something that caused her to become a more authentic version of herself.